Answers are grounded in this paper and cite their sources.
Findings from the literature, coupled with quantification through a novel microsimulation model, demonstrate the potential impact of increased remission on disease trajectory and patient outcomes in MDD. While additional analyses with the model may be warranted to explore the impact of novel interventions on population health, including long-term outcomes (i.e., 5-year follow-up, lifetime follow-up), efforts by clinicians to increase remission early in the disease trajectory may improve long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Arnaud et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: